Medicare will announce negotiated prices for 15 high-cost drugs, impacting over 67 million beneficiaries. The Inflation ...

Manufacturers now face a rapidly evolving landscape where tariffs can shift overnight—from metals to paper to other key ...

Although CNPVs are widely viewed as a valuable opportunity, the criteria for selection remain somewhat opaque. One of the program’s stated goals is to bolster domestic drug production, particularly ...

A new Pharma Pulse briefing unpacks declining RSV vaccine durability in older adults, AstraZeneca’s $2 billion expansion of its US biologics manufacturing footprint, and the stock-shaking Phase III ...

In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...

AstraZeneca's $2 billion investment in Maryland will expand biologics manufacturing and establish a new clinical-stage ...

Abbott's deal shakes up cancer diagnostics, new research confirms pandemic fatigue's impact on public compliance, and more in today’s Pharma Pulse.

In final part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, points out how ...

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...

And finally, urgent care technology company Experity has expanded its partner ecosystem by integrating Amazon Pharmacy into ...

In the second part of his Pharma Commerce video interview, Brad Stewart, BDO’s national life sciences co leader, reveals how ...